Since hepatic NCEH1 is reportedly up-regulated in NAFLD patients [53], this model is considered to be more appropriate for investigating the contribution of F-Chol to the pathogenesis of NASH. This evidence concerns the gene NCEH1 and metabolic dysfunction-associated steatotic liver disease.